+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
All Genders
ID01777828

Registry to Track Survival After Aortic Valve Bioprostheses Implanted by Catheter Including Transarterial and Transapical Approaches

Led by French Cardiology Society · Updated on 2025-02-14

5000

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

This registry focuses on patients who have received aortic valve bioprostheses implanted via catheter through transarterial or transapical routes. It aims to evaluate the overall survival of these patients up to 10 years after implantation. This registry continues previous efforts to assess these valves in patients who were previously considered high risk or unsuitable for traditional surgery, under the oversight of French health authorities. Patients included in this registry have undergone aortic valve replacement using bioprostheses implanted by catheter, following detailed evaluation and approval by cardiac specialists. The registry collects data from all authorized centers in France where this technique is performed, continuing the work of earlier national registries like FRANCE 2. Data collection is standardized and managed by the French Society of Cardiology. Participants are monitored over time through scheduled evaluations to track survival and other health outcomes. The registry links patient data with national health databases to enhance long-term follow-up and ensure comprehensive monitoring up to 10 years. This approach supports understanding of patient prognosis, quality of life, and clinical status following the procedure.

CONDITIONS

Brief Title

Registry of Aortic Valve Bioprostheses Established by Catheter

Research Team

M

Martine GILARD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here